Treatment of hepatocellular carcinoma with tamoxifen: A double-blind placebo-controlled trial in 120 patients
- 1 September 1995
- journal article
- clinical trial
- Published by Elsevier BV in Gastroenterology
- Vol. 109 (3), 917-922
- https://doi.org/10.1016/0016-5085(95)90402-6
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Controlled trial of tamoxifen in patients with advanced hepatocellular carcinomaJournal of Hepatology, 1994
- Phase II study of transarterial embolization in european patients with hepatocellular carcinoma: Need for controlled trialsHepatology, 1994
- Hepatocellular carcinoma: Recent progressHepatology, 1992
- Unresectable hepatocellular carcinoma: a prospective controlled trial with tamoxifenJournal of Hepatology, 1990
- Prognostic factors of hepatocellular carcinoma in the west: A multivariate analysis in 206 patientsHepatology, 1990
- A phase II trial of tamoxifen in hepatocellular carcinomaCancer, 1990
- Renal function abnormalities, prostaglandins, and effects of nonsteroidal anti-inflammatory drugs in cirrhosis with ascites: An overview with emphasis on pathogenesisAmerican Journal Of Medicine, 1986
- Early recognition of hepatocellular carcinomaHepatology, 1986
- Reporting results of cancer treatmentCancer, 1981
- Transection of the oesophagus for bleeding oesophageal varicesBritish Journal of Surgery, 1973